Federated Hermes’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-127
| Closed | -$513 | – | 2222 |
|
|
2023
Q3 | $513 | Hold |
127
| – | – | ﹤0.01% | 2040 |
|
|
2023
Q2 | $521 | Hold |
127
| – | – | ﹤0.01% | 2055 |
|
|
2023
Q1 | $391 | Sell |
127
-1
| -0.8% | -$3 | ﹤0.01% | 2087 |
|
|
2022
Q4 | $344 | Hold |
128
| – | – | ﹤0.01% | 2106 |
|
|
2022
Q3 | $1K | Hold |
128
| – | – | ﹤0.01% | 2087 |
|
|
2022
Q2 | $1K | Hold |
128
| – | – | ﹤0.01% | 2091 |
|
|
2022
Q1 | $1K | Hold |
128
| – | – | ﹤0.01% | 2125 |
|
|
2021
Q4 | $2K | Hold |
128
| – | – | ﹤0.01% | 2068 |
|
|
2021
Q3 | $3K | Buy |
+128
| New | +$3K | ﹤0.01% | 2075 |
|
|
2019
Q2 | – | Sell |
-8
| Closed | -$4K | – | 2228 |
|
|
2019
Q1 | $4K | Sell |
8
-1
| -11% | -$500 | ﹤0.01% | 2008 |
|
|
2018
Q4 | $3K | Buy |
+9
| New | +$3K | ﹤0.01% | 2053 |
|